<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03999242</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL19_0256</org_study_id>
    <nct_id>NCT03999242</nct_id>
  </id_info>
  <brief_title>Charcot Leyden Crystals in Pathology</brief_title>
  <acronym>CLCpath</acronym>
  <official_title>Clinical Significance of Charcot-Leyden Crystals in Bronchial and Sinonasal Pathological Samples</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Charcot Leyden crystals (CLC) are sometime reported in pathological reports of airway or
      sinonasal samples but their clinical significance remain elusive. The investigators organized
      a retrospective analysis of all consecutive patients with CLC seen at our institution between
      1986 and 2019
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In recent years, improved knowledge of eosinophilic inflammation has led to the approval of
      biologics aimed at inhibiting the pathways of eosinophilic activation, notably via the
      interleukin 5 pathway in eosinophilic asthmatic patients uncontrolled despite receiving
      maximum doses of standard drugs. These treatments showed efficacy in asthmatic patients with
      a high level of eosinophils in their induced sputum (&gt; 3%) and the criteria were extended to
      those with circulating eosinophilia (&gt; 300 / mm3). Eosinophils are therefore an important
      biomarker for phenotyping asthmatic patients. The Charcot-Leyden crystals are a reflection of
      the presence of eosinophils, and are sometimes found in some pathological samples. It is
      hypothesized that the presence of Charcot-Leyden crystals, a reflection of tissue
      eosinophilia, is a predictive factor for the efficacy of anti-IL5 biotherapies in patients
      with severe eosinophilic asthma.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">May 15, 2019</completion_date>
  <primary_completion_date type="Actual">May 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>'Level of asthma control/severity according to GINA stepwise approach</measure>
    <time_frame>Baseline (day 0)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>'Level of asthma control/severity according to GINA stepwise approach</measure>
    <time_frame>Baseline (day 0) to Month 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative annualized dose of inhaled and systemic corticosteroids</measure>
    <time_frame>Baseline (day 0) to Month 12</time_frame>
    <description>The quantity of corticosteroids consumed during the course of a year.</description>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Asthma</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bronchial biopsies, sinonasal biopsies, BAL
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients seen at our institution
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Having Charcot Leyden Crystals in a pathological sample

        Exclusion Criteria:

          -  Having Charcot Leyden Crystals in a pathological sample taken outside the airways the
             nose and the sinus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud Bourdin, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uh Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 20, 2019</study_first_submitted>
  <study_first_submitted_qc>June 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2019</study_first_posted>
  <last_update_submitted>June 25, 2019</last_update_submitted>
  <last_update_submitted_qc>June 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nasal polyposis</keyword>
  <keyword>rhinosinusitis</keyword>
  <keyword>Charcot Leyden Crystals</keyword>
  <keyword>Eosinophils</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

